Free Newsletter
Register for our Free Newsletters
Zones
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Materials
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
 
 
Guides
Assay
An assay is a procedure where a property or concentration of an analyte is measured. Numerous types of assays exist, such as an antigen capture assay, bioassay, immunoassay, microbiological assay, stem cell assay to name a few. The links shown on this page feature the key word ′Assay’ in their stories:
FDA Clearance for influenza immunoassay
The Tru Flu rapid immunoassay from Meridian Bioscience for the detection of influenza A and B viruses has received FDA clearance
FDA Clearance for cystic fibrosis assays
The MiSeqDx DNA sequencing analyzer from Illumina receives pre-market clearance from the US FDA
Handheld analyser for measuring lactate
Medica 2013 will see the Lactate Scout+ plus from EKF Diagnostics for point of care handheld lactate analysis
High throughput screening array format
The Infinium HTS-24 arrays can be used to assist in creating understanding genetic predispositions to certain forms of cancer
Immunoassay system improves allergy testing
Immunologists can test for a wider range of allergies with the introduction of 14 new allergens on the Immulite 2000 XPi immunoassay system
Universal sequencing kit for developing diagnostics
CE mark applied to MiSeqDx system for use in the development of diagnostic tests in clinical laboratories
Subsidiary group to focus on study of exosomes
Exosome Sciences to be involved in the diagnostics of serious diseases with the detection and analysis of exosomes in body fluids
New Illumina reagent kits double sequencing output to 15 gigabases
Illumina is introducing new reagent kits for the MiSeq, which claims to be the industry's most accurate and easiest-to-use benchtop sequencer.
Genalyte launches biomarker panel to measure autoantigens associated with the development of Type 1 Diabetes
Genalyte is launching the Type 1 Diabetes (T1D) antigen panel that runs on the Maverick Detection System.
Ariosa Diagnostics, CHU de Quebec and Genome Canada launch study of non-invasive prenatal testing in Canada
A team of researchers led by CHU de Quebec and Universite Laval, has received CAN$10.5 million from Genome Canada, the Canadian Institutes of Health Research (CIHR), Genome Quebec and other partners to conduct a large-scale comparative effectiveness study on non-invasive prenatal screening technique
Genisphere licenses 3DNA dendrimer signal amplification technology to Chembio
Genisphere is licensing the company's 3DNA Signal Amplification technology to Chembio Diagnostics.
Affymetrix introduces new genotyping format to support high-throughput genotyping studies
Affymetrix is introducing the Axiom 384HT genotyping format, a cost-effective, high-throughput format for genotyping in which 384 samples are simultaneously processed with 384 discrete microarrays in a microplate format analysing up to 50,000 SNPs per sample.
Enhanced imaging system improves efficiency in the drug discovery process
PerkinElmer is enhancing Operetta High Content Imaging System, designed to improve the ability of scientists to perform live cell assays with higher throughput, to help foster a better understanding of normal and aberrant cellular behaviour.
Qiagen partners Exosome Diagnostics to develop biofluid sample preparation kits for personalized healthcare
Qiagen is partnering with Exosome Diagnostics to develop and commercialise high-performance sample preparation kits for the processing of nucleic acids from exosomes.
Urine-based cancer detection technology develops ultra-sensitive cell-free DNA assay
Trovagene is reporting the results emerging from ongoing clinical studies have confirmed the broad applicability of Trovagene technology across a variety of cancer types, and the successful development of a molecular diagnostic test capable of detecting and quantifying oncogene mutations from a simp
Bruker releases standardized NMR platform for clinical screening and in vitro diagnostics
Bruker is releasing a standardized nuclear magnetic resonance (NMR) spectroscopy platform for its clinical and diagnostics partners that enables cost-effective, high-performance NMR clinical screening and IVD-by-NMR discovery, development and validation of novel NMR assays.
Luminex receives FDA and European clearance for an updated version of genotyping assay
Luminex receives US FDA and European clearance for a new version of xTAG CYP2D6 Kit and the company has also submitted xTAG 2C19 Kit to FDA for review to advance the company's pharmacogenetic initiative for improved patient care.
Illumina applies CE Mark to cystic fibrosis system
Illumina declares conformity with the requirements of the IVD Directive on June 26, 2013 and has applied the CE mark for the MiSeqDx Cystic Fibrosis System.
Automated Diagenode Bordetella pertussis/parapertussis assay is validated for use on the BD MAX system
BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company), and Diagenode, an international biotech company based in Belgium, are launching in Europe the Diagenode Bordetella pertussis/parapertussis real-time polymerase chain reaction (PCR) kit for use on the B
Quest Diagnostics forms strategic alliance Hologic to improve women's health
Quest Diagnostics enters into a strategic alliance with Hologic to more broadly offer testing based on Hologic's APTIMA family of products, as well as to co-develop and promote advanced diagnostic solutions to improve women's health.
Hamilton Robotics partners Illumina to automate sample preparation for next-generation sequencing
Hamilton Robotics, as part of the co-marketing partnership with Illumina, is developing automated solutions for NGS sample preparation that reduce hands-on time, minimise operational variability, and deliver consistent results.
Oncotest partners Debiopharm Group to identify biomarker candidates
Oncotest and Debiopharm Group a Swiss-based global biopharmaceutical group, complete the first biomarker projects at Oncotest.
Illumina collaborates with Kindstar Global to implement Illumina technologies in Asia
Illumina enters into a strategic collaboration with Kindstar Global which will see Kindstar validating and implementing molecular assays in the company's laboratories, applying Illumina's TruSight content sets, Infinium Dx CytoSNP-12 assay and NuPCR reagents.
Accumetrics receives CE Mark for therapeutic window claim on the VerifyNow P2Y12 test
Accumetrics is seeing the expansion in the intended use for the CE marked VerifyNow P2Y12 Test which will enable physicians to now use the test results to assess whether a patient may be at greater risk for both bleeding or ischemic events, as an aid to manage therapeutic treatment decisions and acc
Luminex receives US FDA clearance for MAGPIX instrument with xTAG gastrointestinal pathogen panel
Luminex receives US FDA clearance of its MAGPIX instrument, with its xTAG Gastrointestinal Pathogen Panel (xTAG GPP).
Boulder Diagnostics launches new parasite detection kits in Europe
Boulder Diagnostics is making European market launch of its ParaFlor kits for the detection of Giardia, Cryptosporidium and Blastocystis infections for human and veterinary applications.
IntelligentMDx receives CE-mark of a test for detection of Influenza A, Influenza B and Respiratory Syncytial Virus
IntelligentMDx (IMDx) obtains CE-marking for a multiplexed, real-time PCR test for detection and differentiation of Influenza A, Influenza B, and Respiratory Syncytial Virus.
New molecular assay to detect Clostridium difficile infection receives FDA clearance
BD Diagnostics receives FDA clearance to market the BD MAX Cdiff Assay in the USA.
Life Technologies introduces two Ion AmpliSeq Community Panel designs
Life Technologies launches two Ion AmpliSeq Community Panels: the Ion AmpliSeq BRCA1 and BRCA2 Panel design and the Ion AmpliSeq Colon and Lung Cancer Panel design.
Firefly BioWorks expands multiplexed microRNA assay solutions
Firefly BioWorks is expanding the company's microRNA assay, FirePlex miRSelect, from a maximum of 23 multiplexed microRNAs to 68.
Alere reveals funding plans to develop affordable point-of-care nucleic acid test for TB
Alere receives a grant of up to $21.6 million and debt financing of up to $20.6 million from the Bill and Melinda Gates Foundation.
Endomagnetics appoints Sysmex Europe to become strategic distributor
Endomagnetics signs a distribution agreement with Sysmex Europe, a subsidiary of global healthcare company Sysmex, which gives Sysmex the exclusive right to provide sales and support for Endomagnetics' SentiMag system across the EMEA region.
Critical Diagnostics completes financing to fund global expansion of cardiac biomarkers
Critical Diagnostics, makers of the Presage ST2 Assay, completes a private placement for an undisclosed amount of capital to expand its commercialization efforts in the USA, Europe and the Asia Pacific reg
Life Technologies unveils benchtop sequencers with 12 new Ion Torrent technology solutions
Life Technologies is unveiling a dozen innovative new products for the Ion Torrent platform that will make sequencing faster, simpler and more accessible for scientists, driving discovery and advancing clinical research around the world.
QIAGEN unveils sample-to-result next-generation sequencing workflow for clinical research and diagnostics
QIAGEN unveils an innovative sample-to-result NGS workflow designed to enable the routine use of a breakthrough technology beyond life sciences research in areas such as clinical research and diagnostics.
Cepheid partners Oregon Health and Science University to develop oncology assays
Cepheid is collaborating with the Knight Cancer Institute at Oregon Health and Science University (OHSU) to develop a menu of advanced molecular diagnostics to be performed on the GeneXpert system.
MP Biomedicals submits Biologic License Application for FDA approval of HTLV confirmatory test
MP Biomedicals submits a Biologic License Application (BLA) for FDA approval of the MP Diagnostics HTLV Blot 2.4, a Western blot for confirmatory testing and viral typing of blood donors and patients.
Labcyte launches first-ever large-volume acoustic liquid handler
Labcyte is adding to the Echo liquid handler product family with what is claimed to be the first-ever large-volume acoustic liquid handler system launched at the annual Society for Laboratory Automation and Screening conference in the USA.
Artel simplifies verification of low-volume DMSO dispenses
Artel is launching the first in a new range of 100 percent DMSO-based Sample Solutions for use with the MVS Multichannel Verification System.
IntelligentMDx enters into multi-year agreement with QIAGEN to develop molecular tests
IntelligentMDx enters into a multi-year development and license agreement with QIAGEN to design, develop and manufacture several undisclosed CE-marked and FDA cleared diagnostic tests for use on QIAGEN's flagship QIAsymphony RGQ automated platform.
Two reference labs sign up With Critical Diagnostics to offer Presage ST2 Assay for heart failure patients
Critical Diagnostics, a US-based biomarker company focused on cardiovascular diseases and Quest Diagnostics and its subsidiary Berkeley HeartLab, announced today an agreement under which both Quest and Berkeley HeartLab will offer ST2 testing services based on Critical Diagnostics’ Presage ST2
Critical Diagnostics signs up four new distributors in Asia
Critical Diagnostics selects Integrated Sciences as the company's exclusive Presage ST2 distributor in Australia, United Laboratories in the Philippines and IDS Medical Systems/Malaysia in Malaysia and IDS Medical Systems/Singapore in Singapore.
New findings show ELISA diagnostics tests are capable of diagnosing Lassa Fever viruses
Corgenix Medical and the Viral Hemorrhagic Fever Consortium (VHFC) releases new scientific data resulting from the consortium's ongoing studies at the Kenema Government Hospital in Kenema, Sierra Leone.
PerkinElmer acquires Shanghai Haoyuan Biotech to complement screening capabilities
PerkinElmer acquires Shanghai Haoyuan Biotech, a China-based infectious disease diagnostics company which will extend PerkinElmer's capabilities into nucleic acid blood screening and in the growing molecular clinical diagnostics market in China, further strengthening the company's position as a di
DioGenix collaborates with Fast Forward to develop blood-based molecular diagnostic for MS
DioGenix is forging an alliance with Fast Forward, a subsidiary of the National Multiple Sclerosis Society, to develop a novel blood test for multiple sclerosis (MS).
Caris Life Sciences selects next-generation sequencer as part of molecular profiling service
Caris Life Sciences selects Illumina's MiSeq sequencing system to support Caris' evidence-based molecular profiling service. The MiSeq system will be deployed to enable rapid, simultaneous analysis of multiple genes from formalin-fixed, paraffin-embedded (FFPE) tumour tissues using Illumina's amp
PerkinElmer launches new epigenetic cellular detection research kits
PerkinElmer launches a panel of nine new epigenetic research assay kits for the detection of endogenous histone modifications at the Revolutionaries for Global Health Summit (RGH), a global scientific community event dedicated to advancing personalized health.
QIAGEN reveals next-generation sequencing initiative to advance routine workflows
QIAGEN is launching the first product in the company's initiative to advance routine workflows in next-generation sequencing (NGS) applications.
Fluidigm unveils quartet of integrated fluidic circuits for production genomics
Fluidigm is introducing four new integrated fluidic circuits (IFCs) designed to meet the challenges associated with production genomics.
BD collaborates with Lab21 Collaborate to develop new oncology assays
BD Diagnostics is to collaborate with Lab21 to develop oncology assays for the BD MAX fully automated, bench-top molecular system.
First | Prev  | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8  | Next  | Last
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com